Ozempic, Wegovy, Mounjaro जैसी GLP-1 दवाओं के Advertisement पर Ban, सरकार ने क्यों उठाया ये कदम? скачать в хорошем качестве

Ozempic, Wegovy, Mounjaro जैसी GLP-1 दवाओं के Advertisement पर Ban, सरकार ने क्यों उठाया ये कदम?

https://www.sensodentk.com/?utm_sourc... Weight-loss drugs like Ozempic, Wegovy and Mounjaro are under scrutiny in India. The Directorate General of Health Services (DGHS) has issued an advisory restricting the promotion of GLP-1 drugs used for Type-2 diabetes and weight loss. Why is the government concerned about misleading ads, and what are the risks of taking GLP-1 medicines without a doctor’s advice? Guest: Dr. Shrey Srivastava, Senior Consultant, Internal Medicine, Sharda Hospital. #health #sehat #WeightLossDrugs #GLP1Drugs The copyright ownership in the video rests with India Today Group. No third party is permitted to use the video without obtaining the permission of India Today Group. Any permission for usage can be obtained through the email ID provided here: mail@lallantop.com. न्यूज़ लेटर के लिए क्लिक करें : https://www.thelallantop.com/newsletter खबरों को विस्तार से पढ़ने के लिए क्लिक करें यहां : https://www.thelallantop.com/ Instagram: @thelallantop Facebook: @thelallantop Twitter: @TheLallantop Production: Aditi Agnihotri Video Editor: Goransh